It is impossible that Abdelbaset al-Megrahi could have pretended to have terminal prostate cancer, according to an oncologist who examined him.
The family of Abdelbaset al-Megrahi, the Lockerbie bomber, loses a posthumous appeal at a top Scottish court against his conviction. Al-Megrahi was the only person convicted for the terrorist attack, whereas his family say that he was the victim of a "miscarriage of justice".
The U.S. Preventive Services Task Force issues a recommendation stating that, in consultation with their doctor and pharmacist, and provided the risk of gastrointestinal bleeding and the very rare risk of certain hemorrhagic strokes do not outweigh the benefits in individual cases, that people aged 50 to 70 (especially those aged 50-60 and with a 10 percent risk or higher of cardiovascular disease, or CVD; mindful that the risk of bleeding, which can be dangerous, goes up as one ages) should take low-dose aspirin, for a period of at least 10 years, for preventive benefits against CVD and heart attack, as well as colorectal cancer. The evidence is inconclusive for those not at very high risk who are over 70, and below 40, and there is only weak evidence for prevention of lung cancer, breast cancer, and prostate cancer.
Abdelbaset al-Megrahi, the only person convicted in the case concerning the 1988 bombing of Pan Am Flight 103, is buried in a private ceremony in a western suburb of Tripoli, having died of cancer aged 60.
Abdelbaset al-Megrahi, the former Libyan intelligence officer convicted of the 1988 bombing of Pan Am Flight 103 over Lockerbie, Scotland, dies at his home in the Libyan capital of Tripoli at the age of 60.
Cardinal Keith O'Brien who leads the Catholic Church in Scotland, defends the Scottish government's decision to release Abdelbaset al-Megrahi for humanitarian reasons and attacks the United States's "culture of vengeance" for trying to coerce Scottish ministers into "crawling like lapdogs".
The Centers for Disease Control and Prevention is currently attempting to gauge the risk of the recently-discovered XMRV virus, linked to rare forms of prostate cancer and chronic fatigue syndrome, to the blood donation supply.